SHStacey L. Hart

Stacey L. Hart

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Stacey L. Hart has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cancer, Prostate

    by Marc A. Kowalkouski, Heather Honoré Goltz, Stacey L. Hart, David Latini

  • Cancer, Bladder

    by Heather Honoré Goltz, Marc A. Kowalkouski, Stacey L. Hart, David Latini


  • Prostate-Specific Antigen (PSA)

    by Marc A. Kowalkouski, Heather Honoré Goltz, Stacey L. Hart, David Latini

  • Prostate

    by Marc A. Kowalkouski, Heather Honoré Goltz, Stacey L. Hart, David Latini

  • Impact of Depression and Anxiety on the Quality of Life of Constipated Patients

    by Jenna J. Albiani, Stacey L. Hart, Laura Katz, Julia Berian, Amanda Del Rosario, Janet Lee, Madhulika Varma

    Constipation negatively affects quality of life (QOL), however, the specific mechanisms through which this relationship occurs are unclear. The present study examined anxiety and depression as potential mediators of the relationship between constipation severity and QOL in a sample of 142 constipated patients. Results indicated that depression symptom severity mediated the relationship between constipation severity and mental health-related QOL. For patients meeting diagnostic criteria for Major Depressive Disorder, indirect effects were observed in the relationship between constipation severity and both physical and mental health-related QOL. Anxiety did not contribute to this model. Treating depression may be useful in improving QOL in severely constipated patients, which highlights the importance of psychological screening and treatment referrals in primary care settings.


  • A randomized controlled trial of anorectal biofeedback for constipation

    by Stacey L. Hart, Janet Waimin Lee, Julia Berian, Taryn R. Patterson, Amanda del Rosario, Madhulika G. Varma

    The purposes of this study were: (1) to examine the efficacy of anorectal biofeedback (AB) for constipation compared to a biofeedback control (BC) treatment and (2) to examine the extent to which self-reported childhood sexual/physical abuse predicted biofeedback outcome. Twenty-one patients with pelvic floor dyssynergia were randomized to either (1) an AB arm, where patients learned to isolate the anal sphincter using an electromyography probe, or (2) a BC arm that controlled for the nonspecific effects of biofeedback, where patients learned to relax trapezius or temporalis muscles with EMG feedback. Both treatments were delivered by registered nurses for six sessions. Prior to randomization and post-treatment, patients completed the validated Constipation Severity Instrument and two measures of quality of life (QOL), the Irritable Bowel Syndrome-QOL, and the SF-36. Generalized estimating equations examined the within-group and between-group differences over time. Pre- and post-treatment data were obtained for six AB and nine BC patients. AB patients' overall constipation severity scores decreased by 35.5% (vs. 15.3%), and their obstructive defecation symptom scores decreased by 37.9% (vs. 19.7%) compared to BC. A similar pattern was shown on the IBS-QOL. On the SF-36 Mental Health Composite (MCS), AB scores improved 28.0% compared to BC scores, which worsened 12.7%. Those without (vs. with) a childhood sexual/physical abuse history showed improvement on the MCS post-biofeedback. While our sample was statistically underpowered, AB produced clinical improvements in constipation severity and QOL.


  • Open Access

    Development and assessment of the constipation‐related disability scale

    by S. L. Hart, J. J. Albiani, C. J. Crangle, L. A. Torbit, M. G. Varma

    Aliment Pharmacol Ther 2012; 35: 183–192Summary: Background  Chronic constipation is associated with impaired quality of life and physical discomfort. Although inability to engage in day‐to‐day activities has been significantly associated with psychological distress, limited research has examined this relationship in constipated samples.Aim  To develop and validate the Constipation‐Related Disability Scale (CRDS), which assesses the extent of disability caused by constipation.Methods  A total of 240 constipated participants and 103 healthy controls completed the CRDS. Reliability was measured with Cronbach’s coefficient alpha and test–retest reliability was assessed with intraclass correlation coefficients. Convergent, divergent and predictive validity were assessed.Results  Component and factor analyses were used to derive two factors: Work/Leisure Activities and Activities of Daily Living, as well as a total CRDS score. Good reliability was found, with alphas ≥0.87 and intraclass correlation coefficients ≥0.85. All scales were negatively correlated with the physical health subscales of the SF‐36 (P < 0.001) and were not significantly correlated with the Epworth Sleepiness Scale and Social Desirability Scale, providing support for convergent and divergent validity, respectively. Evidence of predictive validity was supported by associations between the total CRDS with number of physician visits per year (P < 0.01), missed work in the last year (odds ratio [OR] = 1.11, 95% confidence interval [CI] = 1.06–1.19, P < 0.001) and ER visits in the last year (OR = 1.08, 95% CI = 1.00–1.16, P < 0.05).Conclusions  The Constipation‐Related Disability Scale is the first instrument that assesses the impact of constipation on daily activities. There is evidence of strong reliability and validity of the instrument.


  • Moderators of cancer‐related distress and worry after a pancreatic cancer genetic counseling and screening intervention

    by Stacey L. Hart, Lindsey A. Torbit, Cassandra J. Crangle, Mary Jane Esplen, Spring Holter, Kara Semotiuk, Ayelet Borgida, Paola Ardiles, Heidi Rothenmund, Steve Gallinger

    Objectives: Although the hereditary breast and ovarian cancer literature has demonstrated short‐term gains in psychological adjustment following genetic counseling, there has been limited research examining long‐term outcomes and moderators. Moreover, there has been minimal research into the psychological effects of this intervention in populations at high risk for pancreatic cancer. This study examines the long‐term effects of pancreatic cancer screening and genetic counseling on cancer‐related distress and cancer worry in a high‐risk population at 1‐year follow‐up. Additionally, this study explores potential moderators of the effectiveness of this intervention.Methods: One hundred twenty‐nine participants with familial pancreatic cancer or with the BRCA2 gene mutation completed a baseline questionnaire prior to their first pancreatic cancer screening and genetic counseling session. Participants also completed questionnaires at 3‐ and 12‐month follow‐up.Results: Cancer‐related intrusive thoughts decreased significantly over time, whereas cancer‐related worry decreased at 3 months and showed a small but significant increase at 1 year. Age and baseline distress exhibited moderator effects. Younger individuals showed a significant decrease in cancer‐related intrusive thoughts, cancer‐related avoidant thoughts, and cancer worry. Additionally, individuals with greater baseline distress showed a significant decrease in cancer‐related intrusive thoughts over time.Conclusions: Analysis of the long‐term effects of pancreatic cancer screening and genetic testing reveal psychological gains that are maintained at 1‐year follow‐up. This intervention is particularly effective for younger participants and individuals with greater baseline distress. Copyright © 2011 John Wiley & Sons, Ltd.


  • Improvements in partner support predict sexual satisfaction among individuals with multiple sclerosis.

    by Danielle E. Blackmore, Stacey L. Hart, Jenna J. Albiani, David C. Mohr

    Sexual dysfunction and low sexual satisfaction are common among individuals with multiple sclerosis (MS); however, little is known about factors that influence sexual satisfaction within this population. As such, the purpose of this study was to investigate the extent to which changes in negative and positive partner support predict sexual satisfaction levels over time in individuals with MS. Eighty-one individuals with MS completed measures of sexual dysfunction, sexual satisfaction, partner social support, and depression. Data from baseline and posttreatment follow-up were obtained from a larger randomized clinical trial of telephone-administered psychotherapy for depression in a population with MS. Multiple regression analyses were conducted with change in overall sexual satisfaction from baseline to posttreatment as the outcome variable. After controlling for age, gender, sexual dysfunction, years diagnosed with MS, and depression severity, those with increased positive partner support reported significant improvement in sexual satisfaction over time (β = .50, p < .001), as did individuals with decreased negative partner support (β = .36, p < .01). Results provide evidence that both positive and negative partner support have a distinctive role in the outcome of sexual satisfaction for individuals with MS. Understanding the unique role of positive and negative forms of partner support on sexual satisfaction will help lead to future interventions to improve sexual satisfaction among couples.


  • A Valid and Reliable Measure of Constipation-Related Quality of Life

    by Jennifer Y. Wang, Stacey L. Hart, Janet Lee, Julia R. Berian, G Lindsay McCrea, Madhulika G. Varma

    Few existing measures assess constipation-specific quality of life. This study sought to develop a valid and reliable quality-of-life measure for constipation. First, we created a preliminary instrument that assessed quality-of-life domains affected by constipation: body image, eating, mood, and relationships with others. We conducted focus groups both with patients with constipation seeking treatment and the health care providers who treat them. Next, a 59-item questionnaire was given to 240 subjects with constipation (83% female) and 103 healthy volunteers (63% female). Test-retest reliability and discriminant, convergent, and divergent validity were assessed. Exploratory factor analysis revealed four domains: Social Impairment (five items), Distress (six items), Eating Habits (three items), and Bathroom Attitudes (four items). Internal consistency and test-retest reliability for all subscales was high (Cronbach's alpha = 0.89; intraclass correlation coefficient = 0.87). All domains discriminated well between subjects with constipation and healthy volunteers (P < 0.001). Convergent validity was excellent: all subscales correlated highly with the Irritable Bowel Syndrome Quality of Life Scale total score (P < 0.001) and the Medical Outcomes Study Short Form-36 physical component and mental component summary scores (P < 0.001). Scores from our Constipation-Related Quality of Life measure were not significantly correlated with the Social Desirability Scale, demonstrating divergent validity. Our findings support the reliability and validity of the Constipation-Related Quality of Life measure. Future validation of the Constipation-Related Quality of Life measure for assessing changes in quality of life in response to treatments for constipation is needed.